Washington, United States,
08048034981
+917666132978

Labecanol injection (labetalol hydrochloride) Exporter to Washington, USA |City Drug Exporters INDIA

Leading Labecanol injection (labetalol hydrochloride) Supplier from INDIA to Washington, USA | City Drug Exporters City Drug Exporters supplies Labecanol injection (labetalol hydrochloride) from INDIA to Washington, USA. Trusted pharmaceutical exporter for wholesalers, distributors, pharmacies, and healthcare procurement companies Labecanol injection (labetalol hydrochloride) is a combined alpha- and beta-adrenergic antagonist used for the rapid management of hypertensive emergencies and severe hypertension of pregnancy. It safely lowers blood pressure without significantly altering cardiac output or causing reflex tachycardia. Mechanism of Action : Receptor Blockade: Competitively blocks both alpha-1 and non-selective beta-adrenoceptors. Receptor Ratios: Provides a beta-to-alpha blocking potency ratio of roughly 7:1 intravenously. Vasodilation: Alpha-1 blockade relaxes vascular smooth muscle to reduce total peripheral resistance. Heart Control: Beta-blockade prevents the reflex increase in heart rate normally caused by vasodilation Pharmacokinetics : Onset of Action: Fast onset within 2 to 5 minutes of administration. Peak Effect: Maximum blood pressure reduction occurs within 5 to 15 minutes. Half-life: Elimination half-life of approximately 5.5 hours. Duration of Action: Lasts between 2 to 4 hours. Metabolism: Rapidly metabolized by the liver into inactive glucuronide conjugates. Excretion: Primarily excreted via urine and feces. City Drug House Exporters provides: Bulk supply for hospitals & distributors Export to USA. Washington, INDIA Regulatory documents (COA, MSDS, etc.) Competitive pricing & reliable logistics Contact for More Information : 📞 Contact City drug House Exporters from India 🌐 Websites: https://www.citydrugexporters.com 📧 Email: citydrug123@gmail.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 9975390171
 2026-06-12T08:00:06

Keywords